100 related articles for article (PubMed ID: 6259303)
21. Tc-99m DMSA uptake by metastatic carcinoma of the prostate.
Lamki L; Shearer R
J Nucl Med; 1984 Jun; 25(6):733-4. PubMed ID: 6327947
[No Abstract] [Full Text] [Related]
22. Modified technetium-99m heparin for the imaging of acute experimental myocardial infarcts.
Kulkarni PV; Parkey RW; Wilson JE; Lewis SE; Buja LM; Bonte FJ; Willerson JT
J Nucl Med; 1980 Feb; 21(2):117-21. PubMed ID: 7356749
[TBL] [Abstract][Full Text] [Related]
23. A comparison of radiotracer and biochemical methods for the quantitation of experimental myocardial infarct weight: in vitro relationships.
Kronenberg MW; Ettinger UR; Wilson GA; Schenk EA; Cohen J
J Nucl Med; 1979 Mar; 20(3):224-31. PubMed ID: 24180042
[TBL] [Abstract][Full Text] [Related]
24. 99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.
Miyauchi A; Endo K; Ohta H; Torizuka K; Matsuzuka F; Kobayashi A; Kuma K; Maeda M
World J Surg; 1986 Aug; 10(4):640-5. PubMed ID: 3019022
[No Abstract] [Full Text] [Related]
25. Comparison of Tc-99m pyrosphosphate and Tc-99m hydroxymethylene diphosphonate in acute myocardial infarction: concise communication.
Wakat MA; Chilton HM; Hackshaw BT; Cowan RJ; Ball JD; Watson NE
J Nucl Med; 1980 Mar; 21(3):203-6. PubMed ID: 6245193
[TBL] [Abstract][Full Text] [Related]
26. Re: modified technetium-99m heparin for imaging acute experimental myocardial infarcts.
Hale TI
J Nucl Med; 1980 Dec; 21(12):1203-4. PubMed ID: 7441361
[No Abstract] [Full Text] [Related]
27. Effect of coronary blood flow on uptake and washout of Tc-99m DMPE and Tl-201.
Nishiyama H; Adolph RJ; Deutsch E; Sodd VJ; Libson K; Gerson MC; Saenger EL; Lukes SJ; Gabel M; Vanderheyden JL; Fortman DL
J Nucl Med; 1982 Dec; 23(12):1102-10. PubMed ID: 7143092
[TBL] [Abstract][Full Text] [Related]
28. [The technetium-99-m-pyrophosphate scintigram in the assessment of the size of acute myocardial infarction: comparison with CK-(MB) curves mortality (author's transl)].
Silber S; Schwaiger M; Fleck E; Klein U; Rudolph W
Herz; 1980 Apr; 5(2):101-6. PubMed ID: 6257601
[TBL] [Abstract][Full Text] [Related]
29. [Technetium 99m-diphosphate as an imaging agent in acute myocardial infarction (author's transl)].
Aldor E; Kahn P; Heeger H
Z Kardiol; 1978 Jan; 67(1):13-7. PubMed ID: 629069
[TBL] [Abstract][Full Text] [Related]
30. Techniques for sizing myocardial infarction.
Datz FL; Lewis SE; Stokely EM; Buja LM; Bonte FJ; Parkey RW; Willerson JT
Crit Rev Diagn Imaging; 1981; 15(3):193-236. PubMed ID: 7016443
[No Abstract] [Full Text] [Related]
31. Experimental Study of a Radiopharmaceutical Agent Based on Modified Fatty Acid Labeled with Technetium-99m.
Sazonova SI; Il'yushenkova YN; Lishmanov YB; Tsibul'nikov SV; Skuridin VS; Nesterov EA; Varlamova NV; Il'ina EA; Filimonov VD; Belyanin MV; Stepanova EV; Minin SM
Bull Exp Biol Med; 2017 Apr; 162(6):746-749. PubMed ID: 28429212
[TBL] [Abstract][Full Text] [Related]
32. Formation of labelled colloid in 99Tcm-DMSA due to the presence of bactericidal fluid.
Murray T; Hilditch TE; Whateley TL; Elliott AT
Nucl Med Commun; 1986 Jul; 7(7):505-10. PubMed ID: 3022215
[TBL] [Abstract][Full Text] [Related]
33. [Attempt at scintigraphic quantification of experimental myocardial infarct using pyrophosphate-labeled Tc 99m].
Duska F; Vizda J; Kubícek J; Kafka P; Hájková B; Bastecký J; Morávek F
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1977; 20(2-3):187-93. PubMed ID: 204988
[No Abstract] [Full Text] [Related]
34. A comparison of technetium etidronate and pyrophosphate for acute myocardial infarct imaging.
Williams CC; Nishiyama H; Adolph RJ; Romhilt DW; Sodd VJ; Saenger EL; Gabel M
J Nucl Med; 1977 Sep; 18(9):905-9. PubMed ID: 197134
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen.
Khaw BA; Strauss HW; Carvalho A; Locke E; Gold HK; Haber E
J Nucl Med; 1982 Nov; 23(11):1011-9. PubMed ID: 7131084
[TBL] [Abstract][Full Text] [Related]
36. Re: modified technetium-99m heparin for the imaging of acute experimental myocardial infarcts.
Esquerre JP; Guiraud R
J Nucl Med; 1980 Dec; 21(12):1202-3. PubMed ID: 7441360
[No Abstract] [Full Text] [Related]
37. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
[TBL] [Abstract][Full Text] [Related]
38. Emission-computed tomography and its application to imaging of acute myocardial infarction in intact dogs using Tc-99m pyrophosphate.
Singh M; Berggren MJ; Gustafson DE; Dewanjee MK; Bahn RC; Ritman EL
J Nucl Med; 1979 Jan; 20(1):50-6. PubMed ID: 219165
[TBL] [Abstract][Full Text] [Related]
39. Detection and localization of experimental myocardial infarction with 99m Tc-tetracycline.
Holman BL; Idoine J; Fliegel CP; Davis MA; Treves S; Eldh P; Dewanjee MK
J Nucl Med; 1973 Aug; 14(8):595-9. PubMed ID: 4730349
[No Abstract] [Full Text] [Related]
40. Liposome kinetics in infarcted canine myocardium.
Caride VJ; Twickler J; Zaret BL
J Cardiovasc Pharmacol; 1984; 6(6):996-1005. PubMed ID: 6084791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
